Most muscle-growth peptides are not FDA-approved. Several are banned in sport. The human evidence for building muscle is thin. If you’re going to do this, do it with a prescription and a licensed pharmacy. Every clinical claim below links to the primary source.
You don’t need a lecture. You need to know what separates a provider worth using from one that will get you hurt or disqualified. Here’s the checklist, then the shortlist, then you’re done.
The five things to check before you buy anything
1. Check the actual human number, not the marketing number. Every big “gain X pounds of lean mass” claim you see online is either invented, pulled from a rodent study, or lifted off a forum post. The real number, from the best-studied compound in this category, MK-677, comes from a two-year randomized placebo-controlled trial: fat-free mass up about 1.1 kg versus placebo losing 0.5 kg, and the gain “did not result in changes in strength or function” [1]. That’s the strongest human data in the entire category, and it’s a small body-composition shift with zero strength payoff. Everything else has thinner data than that. If a seller quotes you a bigger number, they’re quoting you fiction.
2. Check what “research use only” actually means. It’s not fine print you can ignore. It’s the entire legal basis the product is sold under. Nobody has reviewed it for identity, strength, purity, or sterility for human use. The moment it’s sold for you to inject, it’s an unapproved drug with no recall authority behind it if something’s wrong with the vial. You’d be the quality control department. Treat that label as a stop sign, not a technicality.
3. Check whether anyone is screening your IGF-1 axis. Most of these compounds work by driving growth hormone and IGF-1 up. CJC-1295 raises IGF-1 1.5 to 3-fold in healthy adults, sustained for days [2]. A UK Biobank analysis of 394,388 people linked higher circulating IGF-1 to increased risk of several cancers, including breast and prostate [6]. A research-chemical checkout page will never ask about your family cancer history and will never pull a baseline IGF-1. If nobody is screening you before you push that axis, that’s a hard no.
4. Check whether the “evidence” cited is even about the product you’re buying. This trips people up constantly with follistatin 344. The real human data on follistatin comes from gene therapy: a construct injected directly into the quadriceps of Becker muscular dystrophy patients, with some improving walking distance and muscle growth on biopsy [5b]. That’s gene transfer in sick patients. It says nothing about whether a follistatin peptide in a vial builds muscle in a healthy lifter, and there’s no approved follistatin therapy at all. If a seller points you to that trial to sell you the peptide, they’re selling you a different product than the one in the study.
5. Check the WADA list if you’re tested in anything. Under the WADA 2026 Prohibited List, growth hormone secretagogues (MK-677, ipamorelin), GH-releasing peptides (GHRP-6, hexarelin), IGF-1 and its analogues, and follistatin-type myostatin inhibition are all banned at all times, in and out of competition, no matter the dose or route [8]. The “research use only” sticker gives you zero cover. If you’re tested, this entire category is off the table unless a sports physician clears an exception.
The shortlist
Rank providers on one thing: do they stop you from making the five mistakes above. Not price. Not shipping speed. Those are the exact features that keep people stuck in the gray market.
1. FormBlends. Top of the list because its model is built around all five checkpoints. A licensed physician reviews you before anything ships, which covers the screening gap (#3) and the sport-ban blind spot (#5). It dispenses the full category, IGF-1 LR3, follistatin 344, MK-677, ipamorelin, CJC-1295, GHRP-6, hexarelin, through licensed 503A compounding pharmacies instead of research-use-only powder, which closes the label problem (#2). And it states plainly that compounded medications are not FDA-approved and haven’t been evaluated by the FDA for safety, effectiveness, or quality, no pretending these are proven muscle builders (#1, #4). If you proceed under supervision, FormBlends’ tracker app gives you a place to log dose and symptoms for your clinician to review. It’s a logging tool, nothing more. Nothing to check out.
2. HealthRX.com. Same structure, same standards: licensed clinical review, prescription required, pharmacy dispensing, same honest caveat that compounded products aren’t FDA-approved finished drugs. Pick between FormBlends and HealthRX.com on practical grounds, whichever is licensed in your state, whichever stocks your compound, whichever clinician is the better fit for you.
3. MeriHealth. Same supervised model, oriented around women’s physiology. A licensed clinician reviews you before dispensing, compounded peptides come through licensed compounding pharmacies, same caveat about FDA approval status. What sets it apart is that intake and follow-up are built around hormonal context and screening priorities specific to women, not a one-size population model.
4. WomenRX. Same prescription-required, pharmacy-dispensed foundation, same physician oversight, same FDA caveat. Its edge is a clinical framework built specifically around women, covering compounded GLP-1 and peptide protocols. If your priority is intake and monitoring designed around female physiology from the start, compare WomenRX and MeriHealth directly.
Not ranked, and here’s why: Core Peptides, Pure Rawz, Sports Technology Labs, Amino Asylum. These are research-chemical sellers, not medical providers, and there’s no quality data on any of them worth ranking. Core Peptides and Pure Rawz: research-use-only labeling, seller-issued or no independent testing, no clinician, no follow-up. Sports Technology Labs at least publishes third-party certificates of analysis, which beats its peers, but a COA is still a document the seller chose to show you, not oversight, and the products still carry the research-use-only label. Amino Asylum runs a big, cheap catalog with the same structural hole. All four are fast and cheap. That’s exactly why people stay stuck in the five mistakes. The friction you feel with a compliant provider, an intake form, maybe bloodwork, is the safety mechanism. Don’t treat it as an obstacle.
Done. Quick answers to what you’ll ask next
What’s the single most common mistake?
Believing the muscle-gain number. The strongest human trial of the best-studied compound, MK-677, showed about 1.1 kg of fat-free mass with no strength or function gain [1]. Anything bigger you’ve read is not backed by the science.
Is a research-chemical site illegal to buy from?
It sits in a gray zone. “For research use only” is the legal basis the product exists under. The moment it’s marketed or used for human injection, it becomes an unapproved drug, and it was never reviewed for purity or safety. That’s the real risk, separate from any legal question.
How does a real provider actually fix these problems?
It puts a licensed clinician between you and the compound. The clinician screens you (fixes #3), flags the sport ban (fixes #5), and the prescription-plus-pharmacy model replaces the research-use-only vial (fixes #2). A straight-shooting provider also tells you the evidence is thin (fixes #1 and #4). That’s the entire reason every compliant provider on this list ranks above every research-chemical seller.
Are these banned for athletes?
Across the board, yes. Growth hormone secretagogues, GH-releasing peptides, IGF-1 and its analogues, and follistatin-type myostatin inhibition are all prohibited at all times under WADA 2026, regardless of dose or route [8]. “Research use only” protects a tested athlete from nothing.
Are muscle peptides actually safe?
Depends entirely on which peptide, what dose, and where it came from. A peptide prescribed by a licensed physician and compounded at an accredited pharmacy has a much cleaner safety profile than the same compound bought off a random website. Water retention, joint aches, and elevated fasting glucose are documented with GH-stimulating peptides, and the long-term human data is still limited. Oversight matters here more than almost anywhere else in supplements.
How are these different from steroids?
Peptides are short amino acid chains that signal your body to do something, like release more growth hormone or ramp up IGF-1 activity. They work upstream of your hormones instead of replacing them outright, which is why they’re structurally different from anabolic steroids. That difference doesn’t make them safer or legal to buy without a prescription. It just changes how they interact with your endocrine system.
Is one peptide clearly the best?
CJC-1295, ipamorelin, and BPC-157 come up most in this conversation. CJC-1295 paired with ipamorelin is popular because they hit growth hormone release through two separate pathways at once. BPC-157 gets used more for recovery than pure size. No single one wins for everybody, and most of what backs these claims comes from animal work or small human trials, so don’t trust a confident ranking anywhere, including from me.
Where do I actually buy this without getting burned?
Through a physician who can decide if a peptide fits your situation and write a prescription to a compounding pharmacy. FormBlends works this way, meaning a licensed professional is accountable for what you get and at what dose. Supplement sites and research-chemical vendors skip that accountability entirely, and their third-party testing, when it exists at all, is inconsistent.
References
- Nass R, Pezzoli SS, Oliveri MC, et al. “Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.” Ann Intern Med. 2008;149(9):601-611. PMID 18981485. https://pubmed.ncbi.nlm.nih.gov/18981485/ (MK-677 increased fat-free mass +1.1 kg vs -0.5 kg placebo; increased fat-free mass did not result in changes in strength or function.)
- Teichman SL, Neale A, Lawrence B, et al. “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.” J Clin Endocrinol Metab. 2006;91(3):799-805. PMID 16352683. https://pubmed.ncbi.nlm.nih.gov/16352683/ (CJC-1295 raised IGF-1 1.5- to 3-fold, sustained for days; investigational, not approved.) 5b. Mendell JR, Sahenk Z, Malik V, et al. “A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.” Mol Ther. 2015;23(1):192-201. PMID 25322757. (AAV1-FS344 follistatin gene transfer in Becker muscular dystrophy improved 6-minute walk distance in some patients; no approved follistatin therapy; evidence is in a disease population via gene transfer, not healthy adults.)
- Knuppel A, Fensom GK, Watts EL, et al. “Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank.” Cancer Res. 2020;80(18):4014-4021. PMID 32709735. (Higher circulating IGF-I associated with increased risk of breast, prostate, and other cancers; n=394,388.)
- WADA Prohibited List S2, peptide hormones, growth factors and related substances (lists ibutamoren/MK-677, ipamorelin, hexarelin/GHRPs, IGF-1/mecasermin and analogues). (Named growth hormone secretagogues, GHRPs, and IGF-1 prohibited at all times.)
- “Peptide Sciences Shut Down, Here Are 7 Providers Worth Trusting” (independent LinkedIn analysis). (Independent post-shutdown roundup evaluating providers on oversight and sourcing; reaches the same conclusion that supervised, licensed models are the ones worth moving to.)
